Fourth Annual Symposium on Nephrogenic Systemic Fibrosis and Gadolinium Based Con
第四届肾源性系统纤维化和钆基Con年度研讨会
基本信息
- 批准号:7915991
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcademyCellsClinicalCollaborationsCommunicationContrast MediaDermatologyDiagnosticDiseaseFASN geneFibrosisFunctional disorderGadoliniumGrantIndividualInternal MedicineKidneyMagnetic Resonance ImagingMedicineNephrologyNew YorkParticipantPathologyPatientsPopulations at RiskPrincipal InvestigatorPublished CommentRadiology SpecialtyRare DiseasesResearchRheumatologyRiskScienceScientistTherapeuticUniversitiesWorkbasecareermedical schoolsmeetingsnext generationprofessorskin disordersymposium
项目摘要
DESCRIPTION (provided by applicant): Yale School of Medicine and The New York Academy of Sciences are planning an important 1.5 day conference entitled, "Fourth Annual Symposium on Nephrogenic Systemic Fibrosis and Gadolinium Based Contrast Agents." This meeting will be held on May 14-15, 2010 at the New York Academy of Sciences, New York. The principal investigator for this conference is Dr. Ali K. Abu-Alfa, MD, FASN; Associate Professor of Medicine; Department of Internal Medicine; Section of Nephrology; Yale School of Medicine; Co PI on this grant is Dr. Shawn E. Cowper, Associate Professor of Dermatology and Pathology; Department of Dermatology; Yale University School of Medicine. This meeting will discuss Nephrogenic Systemic Fibrosis (NSF), a rare skin disorder known to be highly associated with, and very likely triggered by, gadolinium based magnetic resonance imaging contrast agents (GBCA). This man-made disease predominates in individuals with preexisting renal dysfunction. Overall, the breadth of discussions will extend from the cells and atoms responsible for NSF to the entire population at risk. Discussions will examine the therapeutic and mechanistic aspects of NSF as to better understand this rare disease from both a clinical and scientific viewpoint. In addition, the management of patients at-risk in need of MR diagnostic magnetic resonance imaging (MRI) with GBCA will be discussed. Of greater importance, perhaps, is the impact this work will have on the fundamental understanding of fibrosis in general, opening up new avenues of inquiry into disease mechanisms previously thought to be unchallengeable by medicine. This meeting will bring together clinicians and scientists, chiefly in nephrology, radiology, rheumatology, dermatology and pathology. Participants will include both established and young career scientists and clinicians, providing a platform for the next generation to enter this field. Furthermore, this conference is anticipated to increase communication and subsequent collaboration between complimentary research groups.
Project Narrative
This meeting will discuss Nephrogenic Systemic Fibrosis (NSF), a rare skin disorder known to be highly associated with, and very likely triggered by, gadolinium based magnetic resonance imaging contrast agents. This man-made disease predominates in individuals with pre-existing renal dysfunction. Discussions will examine the therapeutic and mechanistic aspects of NSF to examine this rare disease from both a clinical and scientific viewpoint. Of greater importance, perhaps, is the impact this work will have on the fundamental understanding of fibrosis in general, opening up new avenues of understanding into disease mechanisms previously thought to be unchallengeable by medicine.
描述(申请人提供):耶鲁大学医学院和纽约科学院正在筹划一场为期1.5天的重要会议,题为“第四届肾源性系统性纤维化和基于Gd的造影剂的年度研讨会”。本次会议将于2010年5月14日至15日在纽约纽约科学院举行。本次会议的主要研究员是阿里·K·阿布-阿尔法博士,医学博士,FASN,内科副教授,耶鲁大学医学院肾脏病学部,耶鲁大学医学院皮肤病学系副教授肖恩·E·考珀博士。本次会议将讨论肾源性系统性纤维化(NSF),这是一种罕见的皮肤病,已知与基于Gd的磁共振成像造影剂(GBCA)高度相关,并且很可能由其引发。这种人为疾病主要发生在既往存在肾功能障碍的患者中。总体而言,讨论的广度将从负责NSF的细胞和原子延伸到整个面临风险的人群。讨论将检查NSF的治疗和机制方面,以更好地从临床和科学角度理解这种罕见的疾病。此外,还将讨论对需要使用GBCA的MR诊断磁共振成像(MRI)的高危患者的处理。也许,更重要的是,这项工作将对对纤维化的基本理解产生影响,为探索以前被认为是医学上不可挑战的疾病机制开辟了新的途径。这次会议将汇集临床医生和科学家,主要是肾脏病、放射学、风湿病、皮肤病和病理学。参与者将包括成熟的和年轻的职业科学家和临床医生,为下一代进入这一领域提供平台。此外,预计这次会议将加强互惠研究小组之间的交流和随后的合作。
项目叙事
本次会议将讨论肾源性全身性纤维化(NSF),这是一种罕见的皮肤病,已知与基于Gd的磁共振成像造影剂高度相关,并且很可能由其引发。这种人为疾病主要发生在既往存在肾功能障碍的个体中。讨论将检查NSF的治疗和机制方面,以从临床和科学的角度检查这种罕见的疾病。也许更重要的是,这项工作将对对纤维化的基本理解产生影响,为理解以前被认为是医学上不可挑战的疾病机制开辟了新的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ali abu-alfa其他文献
ali abu-alfa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
- 批准号:
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
- 批准号:82070825
- 批准年份:2020
- 资助金额:53 万元
- 项目类别:面上项目
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
- 批准号:81903002
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
- 批准号:81402419
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
- 批准号:81271563
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
- 批准号:31272541
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
- 批准号:31271248
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
- 批准号:81160050
- 批准年份:2011
- 资助金额:49.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Search for damage-associated molecular patterns (DAMPs) derived from cochlear hair cells and its clinical application
耳蜗毛细胞损伤相关分子模式(DAMPs)的探索及其临床应用
- 批准号:
23K08924 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Comprehensive basic research for the development of therapies targeting senescent cells and their clinical applications
针对衰老细胞的疗法开发及其临床应用的综合基础研究
- 批准号:
23H05487 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
PFI-TT: Development of artificial substrates for growth of human stem cells suitable for clinical applications
PFI-TT:开发适合临床应用的人类干细胞生长人工基质
- 批准号:
2234541 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
Elucidation of the molecular mechanism of activated B cells in the pathogenesis of hypersensitivity pneumonitis and its clinical significance.
阐明活化B细胞在过敏性肺炎发病中的分子机制及其临床意义。
- 批准号:
23K07622 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research and development for clinical practical application by analysis of circulation tumor cells of hepatobiliary-pancreatic cancer
肝胆胰癌循环肿瘤细胞分析及临床应用研究进展
- 批准号:
23K14662 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Full-scale GMP Production for a Pre-Clinical Systemic Delivered Mesenchymal Stem Cells Derived Extracellular Vesicles For Cardiovascular Disease
用于治疗心血管疾病的临床前全身输送间充质干细胞衍生的细胞外囊泡的全面 GMP 生产
- 批准号:
10721103 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Rapid, single-step precision engineering and pre-clinical evaluation of chimeric antigen receptor Regulatory T cells for Type 1 diabetes
嵌合抗原受体调节性 T 细胞治疗 1 型糖尿病的快速、单步精密工程和临床前评估
- 批准号:
10477106 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
Development of detection system for oral cancer patient's blood circulating tumor cells and prediction of clinical pathology and prognosis using it
口腔癌患者血液循环肿瘤细胞检测系统的开发及临床病理及预后预测
- 批准号:
22K10146 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
Ultra-high speed AO-OCT clinical system to image ganglion cells and microglia
超高速 AO-OCT 临床系统对神经节细胞和小胶质细胞进行成像
- 批准号:
10547181 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别: